This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Wall Street Investment Banking Gains Momentum: ETFs in Focus
by Sanghamitra Saha
After two years of subdued dealmaking, key Wall Street banks have been witnessing a resurgence in investment banking activity.
M&A to Bounce Back in 2024? ETFs in Focus
by Sanghamitra Saha
After a weak M&A year of 2023, things are looking bright for space due to chances of Fed rate cuts, higher pent-up demand and improving financial markets.
ETFs to Make the Most of the M&A Comeback
by Sweta Killa
After several quiet years, global M&A activity gathered steam early in 2024 following a flurry of deals. The deal value surged 55% year over year to $425 billion, signaling a robust revival in the sector.
What Lies Ahead of M&A ETFs in 2024?
by Sanghamitra Saha
As we move into 2024, optimism around a comeback year for deal-making exists. However, the M&A landscape continues to evolve, with private equity becoming an increasingly attractive option for companies and investors seeking smoother and more predictable exits.
M&A ETF Beats S&P 500 in 2022: What Awaits in 2023?
by Sanghamitra Saha
Dealmaking in the global M&A market has been somewhat muted in 2022 due to a global growth slowdown.
After a Solid 2021, Can M&A & Its ETF Soar in 2022?
by Sanghamitra Saha
U.S. M&A activity totaled $2.5 trillion in 2021, breaching the 2015 peak. Though rising rate worries and a tumbling stock market are drags on the M&A activity in 2022, cash cushion and some emerging trends may buoy this corporate activity this year as well.
Vaccination & Economic Recovery to Boost These ETFs
by Sanghamitra Saha
With COVID-19 vaccination taking momentum, the outlook for large U.S. companies' corporate actions is looking bright.
How to Trade USFDA's EUA to J&J Vaccine With ETFs
by Sanghamitra Saha
On Feb 27, the United States sanctioned Johnson & Johnson's COVID-19 vaccine for emergency use, giving the nation a third vaccine to fight the outbreak, after BioNTech/Pfizer and Moderna.
ETF Areas to Win/Lose With Biden on the Verge of Victory
by Sanghamitra Saha
Though the counting process for the U.S. election outcome is still on, the prospect of a Joe Biden presidency marked by a divided Congress is rife.
M&A ETF (MNA) Hits New 52-Week High
by Sweta Killa
This M&A ETF hits a new 52-week high. Are more gains in store for this ETF?
After a Solid Q3, Can M&A ETF Soar in Q4?
by Sanghamitra Saha
It was a great Q3 for mergers and acquisitions (M&A) that were on hold amid the peak of coronavirus-led lockdowns.
Winning ETF Strategies for Q4
by Sanghamitra Saha
The October-December period will revolve around the events like holiday season, presidential election, vaccine trials and stimulus talks.
After a Record Q3, Can M&A Soar in Q4? ETFs in Focus
by Sanghamitra Saha
Mergers and acquisitions had a great third quarter as deal activities that were on hold amid the peak of coronavirus-led lockdowns opened the floodgates.
M&A ETFs Sizzling on Recent Deal Activities
by Sweta Killa
After tumbling to the lowest level in more than a decade in the second quarter, global M&A activity gathered steam in September following the flurry of latest deal activities.
"Merger Monday" to Benefit These ETFs
by Sanghamitra Saha
Amid coronavirus-related uncertainties, Intel and Nvidia announced two acquisitions that can facilitated their existing portfolio.
Merger Arbitrage ETF (MNA) Hits New 52-Week High
by Sanghamitra Saha
This merger and acquisition ETF hits a new 52-week high. Are more gains in store for this ETF?
How to Replicate Hedge Fund Strategies with ETFs
by Neena Mishra
Liquid alternative ETFs provide access to hedge fund strategies that are not correlated with major asset classes.
M&A ETF (MNA) Hits New 52-Week High
by Sweta Killa
This M&A ETF hits a new 52-week high. Are more gains in store for this ETF?
Global M&A Momentum to Wane in 2019? ETFs in Focus
by Sanghamitra Saha
The year 2019 could see slowdown in global M&A activity.
Bet on These Merger ETFs to Dodge Rising Rates
by Sanghamitra Saha
Merger-arbitrage mutual funds and ETFs have seen inflows close to $1.64 billion through June.
M&A Hits Record in 1H: Ride High With These ETFs
by Sweta Killa
Merger and acquisition activities across the globe hit record highs in the first half of 2018 driven by growing ambition of American companies.
How to Play the Surge in Global M&A With ETFs
by Sanghamitra Saha
M&A ETFs should profit on a substantial surge in deal-making this year.
Is IQ Merger Arbitrage ETF (MNA) a Hot ETF Right Now?
by Sweta Killa
Smart Beta ETF report for MNA
Profit From Record Q1 M&A With These ETFs
by Sweta Killa
Global mergers and acquisitions had their strongest start ever totaling $1.2 trillion in the first quarter of 2018.
Zacks Podcast Highlights: Let's Make a Deal: What's a Merger Arbitrage Strategy?
by Eric Dutram
Merger activity is increasing, and investors need to be prepared. This podcast discusses the 'merger arbitrage' strategy and what you need to know about this approach.